Innovations in AI: Energy Management with EnergyFluo and Biopharma Advancements

Hanwha's EnergyFluo™ Revolutionizes Energy Management

On October 7, 2026, Hanwha proudly announced that their innovative AI energy management system, EnergyFluo™, was named in Fast Company's 2026 Next Big Things in Tech list. Engineered by TransGrid Energy, a Hanwha Group company, EnergyFluo™ is designed to optimize power usage in data centers, enabling them to run more IT capacity with existing power resources. This recognition highlights the system's ability to orchestrate power from multiple sources, including grid, battery storage, and on-site generation.

Technically, EnergyFluo™ employs agentic AI, physics-based equipment models, and digitized operating procedures to analyze real-time data across power generation, battery storage, cooling, and IT loads. By doing so, it helps operators optimize energy use, achieving operational cost savings between 5% to 25% depending on site configurations. The system's autonomy is powered by machine learning and large language models, enabling it to monitor data center operations, analyze potential issues, and optimize power consumption.

The implications for the energy management industry are significant. As data centers become increasingly complex, managing them efficiently is paramount. EnergyFluo™'s capacity to integrate grid, storage, and on-site generation into a single system offers a competitive edge. According to Dr. Youngchoon Park, CEO of TransGrid Energy, "EnergyFluo™ orchestrates grid, storage and on-site generation as one system and optimizes the load behind them." This positions Hanwha as a leader in AI-driven energy solutions, particularly as Prime Group adopts this technology for nationwide edge data centers.

Reflecting on broader trends, the integration of AI in energy management signifies a shift towards more intelligent, adaptive systems. As AI continues to evolve, its role in optimizing critical infrastructure like data centers will likely expand, paving the way for more sustainable and efficient energy use globally.

Veeva Systems: AI Innovations in Biopharma

At the Veeva R&D and Quality Summit held on October 20-21, 2026, in Boston, Veeva Systems showcased its latest AI innovations in the biopharma industry. The summit brought together leading biopharmaceutical companies such as Eli Lilly, Pfizer, and Sanofi to discuss advancements in drug development and quality management. Veeva introduced its vision for 'agentic biopharma,' emphasizing the role of deep AI in clinical, regulatory, safety, and quality operations.

Veeva Systems has developed several AI-powered tools, including Veeva Falcon agentic labor, Vault AI agentic platform, and agents, which are designed to enhance productivity and speed in drug development. These tools facilitate connected trials, enabling seamless collaboration between patients, sites, sponsors, and CROs. Furthermore, Veeva's platforms aim to modernize quality and manufacturing processes by eliminating silos and creating efficiencies.

The adoption of AI in biopharma represents a paradigm shift in how drugs are developed and manufactured. With over 2,500 attendees at the summit, the industry's interest in AI's potential to transform operations is evident. Veeva's commitment to innovation and customer success positions it as a leader in the life sciences industry. As a Public Benefit Corporation, Veeva balances the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.

In my perspective, the integration of AI in biopharma is indicative of a broader trend towards more personalized and efficient healthcare solutions. As AI technologies continue to mature, their ability to streamline complex processes and improve patient outcomes will become increasingly apparent. This evolution could redefine the landscape of drug development and quality assurance in the coming years.

Where Robles.AI Fits

Robles.AI is uniquely positioned to complement these technological advancements. Our expertise in developing intelligent systems aligns with the capabilities showcased by Hanwha's EnergyFluo™ and Veeva Systems. Specifically, our AI-driven analytics and optimization services can enhance energy management solutions like EnergyFluo™ by providing additional insights and predictive capabilities. Additionally, our work in AI for life sciences can support Veeva's initiatives by offering advanced data processing and machine learning models tailored to biopharma needs. As the demand for smart, adaptive technologies grows, Robles.AI is committed to driving innovation and supporting industries in their journey towards a more sustainable and efficient future.